You are here: Industry Insights > COVID-19

News List

T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity worldpharmanews
September 18, 2020
Ever since SARS-CoV-2 first appeared, researchers have been trying to understand whether sometimes the immune system does more harm than good during the acute phase of COVID-19.
BioNTech to Acquire Novartis Mfg. Site for COVID-19 Vax Production contractpharma
September 18, 2020
Will accelerate BioNTech’s efforts to scale-up commercial manufacturing capacity for its mRNA COVID-19 vaccine candidate BNT162.
Lilly’s COVID-19 antibody shows promise in mid-stage study pharmatimes
September 18, 2020
Eli Lilly has reported interim analysis from a Phase II study of its antibody LY-CoV555 in mild-to-moderate recently diagnosed COVID-19 patients, and the data is promising.
IVD industry must be supported in COVID-19 recovery strategy, says BIVDA pharmatimes
September 18, 2020
Ahead of the upcoming comprehensive spending review, The British In Vitro Diagnostics Association (BIVDA) has called for more support for the UK in vitro diagnostics (IVD) industry.
Sorrento gets US FDA nod for Phase 1 clinical trial of neutralising antibody in COVID-19 patients expresspharma
September 18, 2020
Sorrento had earlier informed that COVI-GUARD (STI-1499) demonstrated 100 per cent in vitro neutralizing effect against SARS-CoV-2.
Lilly and Amgen to collaborate for manufacturing COVID-19 antibody therapies expresspharma
September 18, 2020
Together, the companies hope to be able to produce many millions of doses even next year.
More Than Half a Million U.S. Children Already Infected With COVID-19 drugs.com
September 18, 2020
More than 500,000 U.S. children had been diagnosed with COVID-19 as of early September, with a sizable uptick seen in recent weeks, a new report reveals.
Pandemic Threatens Gains in Reducing Preventable Childhood Deaths drugs.com
September 18, 2020
The COVID-19 pandemic threatens decades of progress in reducing preventable deaths in children worldwide, a new United Nations/World Bank paper warns.
AnGes, Brickell Biotech Partner on DNA Vax for COVID-19 contractpharma
September 18, 2020
Advancement of the U.S. based program will be dependent upon results generated from AnGes’ ongoing and planned clinical studies in Japan.
A New Test Could Identify COVID-19 Patients Who Are at Risk for Severe Illness prnewswire
September 18, 2020
A novel study in AACC's Clinical Chemistry journal shows that a new test for SARS-CoV-2 viral proteins known as antigens could determine which COVID-19 patients are most likely to become critically ill.